Company: BKYI
Filing Date: 2025-04-23
Form Type: 10-K
Source: 0001437749-25-012824
Chunk: 468

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-23
Form: 10-K
Item: Item 9
Chunk 468
---
 shares under the 2023 Plan in 2024.

      Number 

      of securities 

      remaining 

      available for 

      Number of 

      future issuance 

      securities to be 

      Weighted- 

      under equity 

      issued 

      average 

      compensation 

      upon exercise 

      exercise price 

      plans 

      of outstanding 

      of outstanding 

      (excluding 

      options, 

      options, 

      securities 

      warrants and 

      warrants and 

      reflected in 

      rights 

      rights 

      column (a)) 

      Plan Category 
      
      (a) 

      (b) 

      (c) 

      Equity compensation plans approved by security holders 

     3,007
      
      (1)(2) 
      
     $
     197.31

     190,285
      
      (3) 

      Equity compensation plans not approved by security holders 

     —

     $
     -

     —

      Total 

     3,007
      
      (1)(2) 
      
     $
     197.31

     190,285
      
      (3) 

      (1) 
      Consists of shares of common stock issuable upon the exercise of options outstanding as of December 31, 2024 under the 2015 Plan and the 2023 Plan. 

      (2) 
      Excludes employee stock purchase rights accruing under the ESPP. 

      (3) 
      Amount includes 529 shares of common stock and 155,957 shares of common stock available as of December 31, 2024 for future issuance under the 2015 Plan and the 2023 Plan, respectively, and 33,799 shares of common stock available as of December 31, 2024 for future issuance under the ESPP. 

    36

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Standstill Agreement with Principal Stockholders

Pursuant to separate securities purchase agreements dated October 29, 2015 and November 11, 2015 with Wong Kwok Fong (Kelvin), we issued and sold shares of series A-1 stock to Kelvin which were subsequently converted into shares of our common stock. The forgoing agreements contain a standstill provision (the “Standstill”) which prohibits Kelvin either alone or together with any other person, from acquiring additional shares